Frontier Wealth Management’s Amgen AMGN Stock Holding History

Frontier Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10.9M	Sell	44,785 -30	-0.1%	-$7.35K	0.79%	26
2022 Q1	$11.2M	Buy	44,815 +245	+0.5%	+$56.3K	0.14%	27
2021 Q4	$10M	Buy	44,570 +5,114	+13%	+$1.08M	0.66%	33
2021 Q3	$8.39M	Sell	39,456 -3,422	-8%	-$788K	0.58%	35
2021 Q2	$10.5M	Sell	42,878 -154	-0.4%	-$37.9K	0.73%	25
2021 Q1	$10.7M	Buy	43,032 +110	+0.3%	+$26.2K	0.82%	23
2020 Q4	$9.87M	Buy	42,922 +627	+1%	+$145K	0.81%	24
2020 Q3	$10.8M	Sell	42,295 -1,500	-3%	-$372K	0.99%	19
2020 Q2	$10.3M	Buy	43,795 +813	+2%	+$185K	0.95%	21
2020 Q1	$8.71M	Buy	42,982 +15,384	+56%	+$3.36M	1.42%	10
2019 Q4	$6.65M	Sell	27,598 -16,298	-37%	-$3.59M	1.07%	20
2019 Q3	$8.49M	Sell	43,896 -1,473	-3%	-$283K	1.25%	18
2019 Q2	$8.36M	Sell	45,369 -787	-2%	-$141K	1.23%	14
2019 Q1	$8.77M	Buy	46,156 +338	+0.7%	+$64.5K	1.19%	15
2018 Q4	$8.92M	Buy	45,818 +354	+0.8%	+$69.1K	1.35%	12
2018 Q3	$9.42M	Sell	45,464 -2,890	-6%	-$570K	0.9%	12
2018 Q2	$8.93M	Sell	48,354 -1,021	-2%	-$181K	1.28%	13
2018 Q1	$8.42M	Sell	49,375 -8,025	-14%	-$1.47M	1.18%	15
2017 Q4	$9.98M	Sell	57,400 -96	-0.2%	-$17K	1.6%	11
2017 Q3	$10.7M	Sell	57,496 -1,571	-3%	-$278K	1.54%	11
2017 Q2	$10.2M	Buy	59,067 +714	+1%	+$116K	1.56%	9
2017 Q1	$9.57M	Buy	58,353 +3,529	+6%	+$586K	1.47%	9
2016 Q4	$8.02M	Buy	54,824 +3,212	+6%	+$483K	1.31%	11
2016 Q3	$8.61M	Sell	51,612 -1,871	-3%	-$316K	1.31%	11
2016 Q2	$8.14M	Buy	53,483 +19	+0%	+$2.95K	1.3%	13
2016 Q1	$8.02M	Buy	53,464 +1,297	+2%	+$193K	0.67%	13
2015 Q4	$8.47M	Sell	52,167 -174	-0.3%	-$27.4K	1.36%	11
2015 Q3	$7.24M	Buy	52,341 +10,768	+26%	+$1.7M	1.14%	16
2015 Q2	$6.38M	Buy	41,573 +35,973	+642%	+$5.76M	0.98%	20
2015 Q1	$895K	Sell	5,600 -751	-12%	-$118K	0.14%	112
2014 Q4	$1.01M	Buy	+6,351	New	+$990K	0.19%	87

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Frontier Wealth Management's AMGN Position: Q2 2022 in Review

Frontier Wealth Management reduced its Amgen (AMGN) stake by 0.07% in Q2 2022, selling an estimated $7.35K and leaving 44,785 shares worth $10.9M. The position accounts for 0.79% of the portfolio, ranked #26.

Frontier Wealth Management first reported a position in AMGN in Q4 2014 and has held it in 31 quarters since. The position peaked at $11.2M in Q1 2022. 2,353 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

Frontier Wealth Management held 44,785 shares of Amgen worth $10.9M as of Q2 2022.
Frontier Wealth Management sold 30 Amgen shares in Q2 2022, an estimated $7.35K.
Amgen made up 0.79% of Frontier Wealth Management's portfolio in Q2 2022, its #26 holding.
Frontier Wealth Management first reported a position in Amgen in Q4 2014 and has held it in 31 quarters since.
Frontier Wealth Management's Amgen position peaked at $11.2M in Q1 2022.
2,353 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.